How much has Nourish raised?
Nourish has $215M in disclosed or reported funding. The latest public valuation/status is Unicorn status reported; latest valuation not disclosed.
- Total raised
- $215M
- Disclosed rounds
- 4 major disclosed entries
- Latest round
- Series C ($100M)
- Latest valuation
- Unicorn status reported; latest valuation not disclosed
- First raised
- 2023 Seed
- Notable backer
- Menlo Ventures
Nourish's funding rounds
Nourish's public funding trajectory runs from 2023 to 2026.
- 2023Seed — valuation not disclosedundisclosed/early led/backed by Y Combinator and early investors.
- Mar 2024Series A — valuation not disclosed$35M led/backed by Index Ventures.
- Apr 2025Series B — over $1B valuation reported$70M led/backed by J.P. Morgan Growth Equity Partners.
- 2026Series C — valuation not disclosed$100M led/backed by Menlo Ventures.
Sources:Nourish homepageNourish Series BIndex Nourish Series B
How much has Nourish raised in total?
Nourish has $215M in disclosed or reported funding. The profile lists only public amounts and clearly marks undisclosed valuations or rounds.
The major funding entries are 2023 Seed: undisclosed/early, valuation not disclosed, led/backed by Y Combinator and early investors; Mar 2024 Series A: $35M, valuation not disclosed, led/backed by Index Ventures; Apr 2025 Series B: $70M, over $1B valuation reported, led/backed by J.P. Morgan Growth Equity Partners; 2026 Series C: $100M, valuation not disclosed, led/backed by Menlo Ventures.
Who are Nourish's investors?
Notable investors or backers include Y Combinator and early investors, Index Ventures, J.P. Morgan Growth Equity Partners, Menlo Ventures. These investors are relevant because they shape board expectations around growth, governance, hiring, and follow-on capital discipline.
Why did the valuation move or stay undisclosed?
The latest public valuation is Unicorn status reported; latest valuation not disclosed. The valuation is tied to market demand, product differentiation, growth expectations, and proof that the company can scale healthcare outcomes or workflow ROI.
Is Nourish profitable, and will it IPO?
Nourish has not publicly disclosed audited profitability or IPO timing. Treat IPO readiness as speculative until management files, announces a transaction, or publishes financials.
What does Nourish's funding mean if you sell into them?
The funding signal suggests budget capacity, but not automatic spend. Sellers should map to the active initiative funded by the round: market expansion, clinical operations, AI/data tooling, compliance, workforce, integrations, or payer/provider partnerships.
As of June 2026.Sources:Nourish homepageNourish Series BIndex Nourish Series BForbes Nourish Series B
Nourish — frequently asked questions
